Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02167633Terminated
Randomised, open-label trial (2 arms), sponsored by Rigshospitalet. Primary endpoint: Ability to walk at 6 weeks. Started Jul 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02167633.